JavaScript is disabled. Please enable to continue!

Mobile search icon
Eurofins >> Cosmetics >> Media Centre >> News >> Bio-EC, Spincontrol and Genex, part of Bio-EC / Spincontrol Group, join the Eurofins network of companies

Bio-EC, Spincontrol and Genex, part of Bio-EC / Spincontrol Group, join the Eurofins network of companies

Sidebar Image

Eurofins Cosmetics and Personal Care

 

Bio-EC, Spincontrol and Genex, part of Bio-EC / Spincontrol Group, join the Eurofins network of companies

 

Eurofins has successfully completed the acquisition of a majority stake in Bio-EC, Spincontrol and Genex, part of Bio-EC / Spincontrol Group, as part of its ambitions to further expand its global Cosmetics & Personal Care offering. The acquisition adds ex vivo objectivation and cosmetogenomic capabilities and strengthens the Eurofins Group’s ability to perform ad-hoc clinical efficacy studies, emotion studies, and image analysis.

By joining forces, Eurofins Cosmetics & Personal Care (C&PC) and Bio-EC, Spincontrol and Genex will leverage their respective expertise and capabilities to provide creative, unique and integrated solutions for cosmetics, food supplements and medical devices. 

The French-based companies are headquartered in Paris and Tours, with three facilities in France and Canada, and employ 58 people.

 

With 24 years of experience, Bio-EC brings innovative capabilities to Eurofins, with a strong position in ex vivo models and mechanisms and in vitro toxicology services, as well as new clinical facilities in Paris and unique expertise with its own in-house RAMAN. With the most sophisticated research and development capabilities, and equipment, Bio-EC is involved in several research and innovation projects and channels its expertise into offering new models and methods each year. 

 

One of the industry’s most experienced and influential companies in clinical efficacy studies, Spincontrol France and Spincontrol Canada support Eurofins Cosmetics & Personal Care’s ambition to consolidate its portfolio and capture the value it brings to its customers. Well-known in the market, thanks to their 31 years of experience, Spincontrol will allow Eurofins C&PC to expand upon existing clinical capabilities, ad-hoc testing protocols and emotion studies, open access to in-house image analysis, and new shooting technologies, and bring its companies closer to local and regional customers in France and Canada.  

 

Genex's expertise in cosmetogenomics will support Eurofins C&PC in offering new gene expression monitoring to its customers, to comprehensively identify product effects and reveal new targets and mechanisms.

 

About Bio-EC, Spincontrol, Genex

 

 

Since 1998, Bio-EC is specialized in the evaluation of the effectiveness of cosmetic and dermatological products (finished products or active ingredients), but also medical devices and food supplements.

Its activity is organized around several poles:

  • Ex vivo studies on human skin explants maintained in survival
  • ln vivo studies on a panel of healthy volunteers
  • Dermal absorption studies
  • RAMAN spectroscopy studies

All the studies performed are customizable to best meet cosmetic and dermatological objectification needs.

 

Read more

 

With 30 years of experience, Spincontrol is a laboratory specialized in the evaluation of in vivo efficacy of any product with cosmetic, aesthetic or well-being claims, according to five approaches: instrumental, clinical, emotional, sensorial and consumer.

Recognized as one of the most innovative laboratories, their tests are genuine promotional support of products, in two locations based in France, Canada, and through 3 partners in Thailand, lndia and lndonesia.

Our philosophy is to provide technological knowledge and know-how to our customers with honesty, transparency and ethics, under a recognized system of quality standard, ISO 9001.

 

Read more

Read more

 

Created in 2012, GENEX Laboratory is specialized in Cosmetogenomic studies: the response of genes to cosmetics.

With one study, GENEX Laboratory can highlight all your products activities:

  • Cosmetogenomics (DNA chip/Qpcr/miRnome... )
  • Screening/Repositioning of active ingredients
  • Identification of new claims
  • Discovery of biological effects
  • Protective effect against the exposome

GENEX Laboratory is able to provide cosmetic companies with innovative technologies, in order to answer new needs in claim substantiation.

 

Read more

 

About Eurofins Cosmetics & Personal Care

 

Eurofins Cosmetics & Personal Care is the leading provider in cosmetics and personal care testing worldwide, offering the most comprehensive service portfolio from its state-of-the-art cosmetics testing laboratories across the globe. With a network of over 30 high-level laboratories active in the field across Europe, North America, Asia-Pacific and Africa, Eurofins Cosmetics & Personal Care offers an unmatched range of services to both top-tier international and local clients, including: regulatory and toxicological services, physico-chemical analyses, microbiology, ecotoxicity and biodegradability, in vitro testing, clinical studies, consumer tests and sensory evaluation, and audit and consulting services.

Eurofins Cosmetics & Personal Care is part of the Eurofins Group.

 

About Eurofins 

 

Eurofins is Testing for Life. Eurofins is the global leader in food, environment, pharmaceutical and cosmetic product testing, and in discovery pharmacology, forensics, advanced material sciences and agroscience Contract Research services. Eurofins is also a market leader in certain testing and laboratory services for genomics, and in the support of clinical studies, as well as in BioPharma Contract Development and Manufacturing. The Group also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products.

 

With over 61,000 staff across a network of 900 laboratories in 61 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.